Friday, February 20, 2026
19.4
C
Bengaluru
Hot topics
What about Indian Pharma?
Articles by K. Hariram, Vivek Hattangadi, Soham Wagh, Dr. Rajshri Jobanputra, and Rashesh Patel
Digital as Emergent Strategy – Lessons for Pharma from Honda
The door to the magical realm is open! Are...
Customer Engagement and Experience are the New Differentiators
At the IDMA Marketing and Sales Conference in Mumbai...
Legal Scrutiny
The October 2016 Issue of MedicinMan features articles by K. Hariram, Vivek Hattangadi, Anup Soans and has a special focus on ethics and morals in the healthcare profession. Other topics covered include new product launches, the role of emotions in pharma sales and sales coaching.
Medical Affairs, Marketing and Sales – The Triumvirate of Pharmaceutical Business
The Medical department comprising of Clinical Operations (the ones...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
Hot topics
Astra Zeneca Tops Indian Pharma in New Introductions 2024
Analysis of Indian Pharmaceutical Market (IPM) – 2024
This data...
The Uncomfortable Truth about Indian Generics: Untangling the Conundrum
India’s pharmaceutical industry occupies a unique and powerful position...
From VUCA to TACO: Thriving in a Chaotic World
From VUCA to TACO: Thriving in a Chaotic World
Leaders...
GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug
In a bold move to strengthen its hepatology pipeline,...
Managed Healthcare – Better Choice for India?
Managed care shifts healthcare from fragmented fee-for-service models to...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
India’s Pharma Renaissance: Private Equity at the Helm
Indian pharmaceuticals have long been known as the “pharmacy...
The ₹5 Snack SKU: A Silent Indian Metabolic Crisis
Executive Summary — The Paradox of Scale
In the annals...
Sleep Apnea: Apnimed Pill to Replace CPAP Machine?
In India, where urban sleep debt is rising, obesity...
Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich
When a new cancer drug shows promise, it trends...
Newsletter
Get important news delivered directly to your inbox and stay connected!